Allspring Global Investments Holdings, LLC Atara Biotherapeutics, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$59.4 Billion
Q2 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$1.41 - $2.31 $54,943 - $90,013	38,967 New	38,967 $57,000
Q2 2023 Jul 18, 2023	BUY	$1.5 - $3.04 $31,951 - $64,755	21,301 Added 47.23%	66,404 $106,000
Q1 2023 Apr 13, 2023	SELL	$2.8 - $5.46 $1,668 - $3,254	-596 Reduced 1.3%	45,103 $130,000
Q4 2022 Jan 23, 2023	BUY	$2.85 - $5.18 $21,457 - $39,000	7,529 Added 19.72%	45,699 $0
Q3 2022 Oct 26, 2022	BUY	$2.85 - $8.73 $27,012 - $82,742	9,478 Added 33.03%	38,170 $144,000
Q2 2022 Jul 25, 2022	BUY	$4.69 - $9.84 $328 - $688	70 Added 0.24%	28,692 $223,000
Q1 2022 May 02, 2022	SELL	$8.44 - $16.89 $159,313 - $318,815	-18,876 Reduced 39.74%	28,622 $265,000
Q4 2021 Jan 28, 2022	BUY	$14.7 - $19.89 $698,220 - $944,735	47,498 New	47,498 $748,000

Others Institutions Holding ATRA

# of Institutions

Shares Held

3.07M

Call Options Held

Put Options Held

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $720M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account